2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5 Remdesivir Intermediate COVID-19
Ubonelelo ngezoRhwebo loMvelisi i-Remdesivir kunye nabaPhakathi abaNxulumeneyo nabanoMgangatho oPhezulu
I-Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
I-Trimethylsilyl Cyanide CAS 7677-24-9
I-4-Nitrophenol CAS 100-02-7
I-2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
I-Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
I-Remdesivir N-2 ePhakathi CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
I-Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Igama leMchiza | 2,3,5-Tri-O-benzyl-D-ribonolactone |
Izithethantonye | 2,3,5-Tri-O-Benzyl-D-Ribono-1,4-Lactone;I-Remdesivir ePhakathi |
Inombolo yeCAS | 55094-52-5 |
Inombolo yeCAT | RF-PI301 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | C26H26O5 |
Ubunzima beMolekyuli | 418.49 |
Indawo yokunyibilika | 54.0-55.0℃ |
Imeko yoGcino | Ubushushu beGumbi |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umthubi okanye oMhlophe Okuqinileyo |
Ukunyibilika | I-Soluble kwi-CH2Cl2 kunye ne-Insoluble kwi-H2O |
I-NMR kunye ne-MS | Kufuneka Uthobele |
Ukuchongwa | I-IR kunye ne-TLC |
Ukufuma | ≤1.0% |
Intsalela kwi-Ignition | ≤0.50% |
Nakuphi na Ukungacoceki komntu | ≤0.50% |
Iintsimbi ezinzima | ≤50ppm |
I-HPLC (210nm) | ≥99.0% |
I-HPLC (ELSD) | ≥99.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi we-Remdesivir (CAS 1809249-37-3) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-2,3,5-Tri-O-benzyl-D-ribonolactone (i-CAS 55094-52-5) yi-Remdesivir ephakathi.I-Remdesivir (CAS 1809249-37-3) lichiza eliyinoveli le-antiviral kudidi lwe-nucleotide analogs, elisetyenziswa kunyango lwe-COVID-19.I-Remdesivir (GS-5734) yi-analogue ye-antiviral nucleoside enoveli enqanda intsholongwane ye-murine hepatitis (MHV) ene-EC50 efanayo ne-SARS-CoV kunye ne-MERS-CoV.IiCoronavirus (CoVs) ziintsholongwane ezinemisonto enye ye-RNA ezosulela uluhlu olubanzi lwezilwanyana.Ebantwini, ii-CoVs zaqatshelwa njengesiqhelo ezibangela ukubanda kunye nenyumoniya de kwavela i-acute acute breathing syndrome (SARS-CoV) ngo-2002 kunye ne-Middle East Respiratory Syndrome coronavirus (MERS-CoV) ngo-2012 ukusuka kwimithombo yezoonotic.I-Remdesivir yi-monophosphoramidate prodrug ye-C-adenosine nucleoside analogue GS-441524.Kwiiseli ezibambezelekayo zobuchopho (DBT) ezosulelwe yi-MHV, i-GS-5734 inqande i-MHV ngokunamandla ngaphezu kwe-GS-441524, kunye ne-GS-5734 EC50 ye-0.03 M. Ngaphezu koko, ixabiso le-EC50 limiselwe emva konyango nge-GS-441524 kunye ne-GS-5734 kunye ne-GS-5734 kwiinkcubeko ze-SARS-CoV- kunye ne-MERS-CoV-ezosulelwe umgaqo womoya woluntu we-epithelial cell (HAE).